Article Text
Abstract
Background While mitochondrial DNA (mtDNA) copy number is strictly regulated during differentiation and according to cell type, very little is known regarding the mechanism which accurately controls mtDNA copy number in human. Exon 2 of the human POLG gene, encoding the catalytic subunit of the mitochondrial-specific DNA polymerase gamma, contains a CpG island, highly conserved in mice and human. Changes of DNA methylation at the POLG locus have been shown to modulate mtDNA copy number during cell differentiation in both mouse and human.
Methods We have investigated the epigenetic modification of the POLG gene, by assessing the methylation level of its exon 2 using deep-Next Generation Sequencing analysis of bisulfite-treated DNA. Analysis were performed on various tissues at either postnatal or prenatal stages, on samples from carriers of mtDNA mutations, patients carrying two loss-of-function POLG mutations and controls.
Results Very high methylation levels at POLG exon 2 were found (94±3%) and no variation was observed according to either developmental stage or tissue of origin, except for sperm samples for which lower methylation levels were found (80%). This high level of methylation was neither correlated with the presence of mtDNA mutations (94±1% of methylated alleles), nor with biallelic POLG mutations (93%±2%), even in tissues where a mtDNA depletion had been observed.
Conclusions This study suggests that, at variance with mouse and un/de-differentiated human cells, differentiated human cells control mtDNA levels irrespective of POLG methylation. The factors which actually control the mtDNA levels in such cell types remain to be identified.
- methylation
- POLG
- mitochondrial DNA
- mitochondria
- mutation
Statistics from Altmetric.com
Footnotes
Contributors JS and J-PB planned and supervised the study. AP and HA performed the experiments. CB, LR-G, JM and AR contributed to reagents, materials and analysis tools. Bioinformatic data analysis was performed by CF and FT. JS and J-PB analysed the data. JS, JP-B and AM wrote the manuscript.
Funding This work was supported by “Agence de la Biomedecine”.
Competing interests None declared.
Ethics approval Agence de la Biomedecine.
Provenance and peer review Not commissioned; externally peer reviewed.